BE870548A - Nouveau procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnostic - Google Patents

Nouveau procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnostic

Info

Publication number
BE870548A
BE870548A BE190539A BE190539A BE870548A BE 870548 A BE870548 A BE 870548A BE 190539 A BE190539 A BE 190539A BE 190539 A BE190539 A BE 190539A BE 870548 A BE870548 A BE 870548A
Authority
BE
Belgium
Prior art keywords
cosmetic
pharmaceutical
preparation
new process
diagnosis forms
Prior art date
Application number
BE190539A
Other languages
English (en)
French (fr)
Original Assignee
Lafon Labor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lafon Labor filed Critical Lafon Labor
Publication of BE870548A publication Critical patent/BE870548A/xx

Links

Classifications

    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F26—DRYING
    • F26B—DRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
    • F26B5/00—Drying solid materials or objects by processes not involving the application of heat
    • F26B5/04—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum
    • F26B5/06—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum the process involving freezing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A61K8/0283—Matrix particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
    • A61K8/8176—Homopolymers of N-vinyl-pyrrolidones. Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/22—Gas releasing
    • A61K2800/222—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/524—Preservatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60—Particulates further characterized by their structure or composition
    • A61K2800/65—Characterized by the composition of the particulate/core
    • A61K2800/652—The particulate/core comprising organic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/84—Products or compounds obtained by lyophilisation, freeze-drying

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Physics & Mathematics (AREA)
  • Mathematical Physics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Mechanical Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Drying Of Solid Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BE190539A 1977-09-19 1978-09-18 Nouveau procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnostic BE870548A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7728193A FR2403078A1 (fr) 1977-09-19 1977-09-19 Nouveau procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnostic

Publications (1)

Publication Number Publication Date
BE870548A true BE870548A (fr) 1979-03-19

Family

ID=9195532

Family Applications (1)

Application Number Title Priority Date Filing Date
BE190539A BE870548A (fr) 1977-09-19 1978-09-18 Nouveau procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnostic

Country Status (15)

Country Link
US (1) US4178695A (de)
JP (1) JPS5495720A (de)
BE (1) BE870548A (de)
CA (1) CA1097209A (de)
CH (1) CH633445A5 (de)
DE (1) DE2840461A1 (de)
DK (1) DK154528C (de)
ES (1) ES473459A1 (de)
FR (1) FR2403078A1 (de)
GB (1) GB2004182B (de)
IE (1) IE47020B1 (de)
IT (1) IT1106901B (de)
LU (1) LU80251A1 (de)
NL (1) NL186675C (de)
SE (1) SE444645B (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1209477A (en) * 1981-03-26 1986-08-12 Bruce E. Haeger Composition of matter comprising a lyophilized preparation of a penicillin derivative
US4429542A (en) * 1981-08-10 1984-02-07 Hoxan Corporation Method of freezing fertilized ova, spermatozoa or the like and apparatus therefor
JPS58154547A (ja) * 1982-03-09 1983-09-14 Nippon Shinyaku Co Ltd アズレン誘導体の安定化法
ES525492A0 (es) * 1982-09-10 1985-02-01 Glaxo Group Ltd Un procedimiento para la produccion de un recipiente hermeticamente cerrado que contiene al menos un antibiotico de beta-lactama.
FR2539626B2 (fr) * 1983-01-25 1985-06-21 Lafon Labor Nouveau procede de preparation de formes galeniques utiles notamment en therapeutique, dietetique, cosmetique et diagnostic, et formes obtenues selon ce procede
US4642903A (en) * 1985-03-26 1987-02-17 R. P. Scherer Corporation Freeze-dried foam dosage form
US4712310A (en) * 1986-09-15 1987-12-15 E. I. Du Pont De Nemours And Company Co-spray technique
IL86892A (en) * 1987-07-08 1993-04-04 Lafon Labor Filter comprising a material obtained by freeze-drying, its preparation and its use, especially in pharmacy
JP2865320B2 (ja) * 1989-08-07 1999-03-08 株式会社資生堂 固型化粧料組成物
FR2670675B1 (fr) * 1990-12-20 1993-04-16 Lafon Labor Procede de preparation de formes pharmaceutiques stables a base d'acide acetylsalicylique ou de ses sels.
IL101007A (en) * 1992-02-18 1997-08-14 Pharmos Ltd Dry stable compositions prepared by lyophilization
FR2702968B1 (fr) * 1993-03-23 1995-06-23 Lafon Labor Procédé de préparation de particules renfermant un ingrédient actif par extrusion et lyophilisation .
DE4342091A1 (de) * 1993-12-09 1995-06-14 Asta Medica Ag Erzeugnisse zur Anwendung von initial hohen Dosen von Cetrorelix und Herstellung einer Kombinationspackung zur Verwendung bei Therapie von Krankheiten
US8236352B2 (en) 1998-10-01 2012-08-07 Alkermes Pharma Ireland Limited Glipizide compositions
US20040013613A1 (en) * 2001-05-18 2004-01-22 Jain Rajeev A Rapidly disintegrating solid oral dosage form
US6316029B1 (en) 2000-05-18 2001-11-13 Flak Pharma International, Ltd. Rapidly disintegrating solid oral dosage form
US6982251B2 (en) * 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
PT1363668E (pt) * 2001-01-26 2007-11-07 Schering Corp Combinaçoes de sequestrante(s) de ácidos biliares e inibidor(es) de absorção de esterol e tratamento de indicações vasculares
CZ20032031A3 (cs) * 2001-01-26 2003-12-17 Schering Corporation Farmaceutický prostředek
CA2434504A1 (en) * 2001-01-26 2002-08-01 Teddy Kosoglou Combinations of sterol absorption inhibitor(s) with blood modifiers for treating vascular conditions
AR034204A1 (es) * 2001-01-26 2004-02-04 Schering Corp Composiciones y combinaciones de acido nicotinico y derivados del mismo con inhibidor(es) de la absorcion de los esteroles, y el uso de los mismos para preparar medicamentos para el tratamiento para indicaciones vasculares
CZ305202B6 (cs) * 2001-01-26 2015-06-10 Merck Sharp & Dohme Corp. Farmaceutický prostředek
US7071181B2 (en) * 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
CZ309209B6 (cs) * 2001-01-26 2022-05-25 Schering Corporation Farmaceutický prostředek
EP1392287B8 (de) * 2001-05-25 2007-01-10 Schering Corporation Verwendung von substituierten Azetidinonderivaten in der Behandlung der Alzheimer-Krankheit
US20030119808A1 (en) * 2001-09-21 2003-06-26 Schering Corporation Methods of treating or preventing cardiovascular conditions while preventing or minimizing muscular degeneration side effects
MXPA04002572A (es) * 2001-09-21 2004-05-31 Schering Corp Metodos para el tratamiento o prevencion de inflamacion vascular usando inhibidores de absorcion de esterol.
EP1429756B1 (de) * 2001-09-21 2006-11-22 Schering Corporation Behandlung von xanthom mittels azetidinon-derivate als hemmer der sterol absorption
US7056906B2 (en) * 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
US7053080B2 (en) * 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
PT1443912E (pt) * 2001-10-12 2007-11-28 Elan Pharma Int Ltd Composições tendo uma combinação de características de libertação imediata e de libertação controlada
CA2479735C (en) * 2002-03-20 2011-05-17 Elan Pharma International Ltd. Fast dissolving dosage forms having reduced friability
JP2006508188A (ja) * 2002-11-06 2006-03-09 シェーリング　コーポレイション 脱髄の処置のためのコレステロール吸収インヒビター
EP1606287B1 (de) * 2003-03-07 2013-10-02 Merck Sharp & Dohme Corp. Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia
MXPA05009501A (es) 2003-03-07 2005-10-18 Schering Corp Compuestos de azetidinona sustituidos, formulaciones y usos de los mismos para el tratamiento de hipercolesterolemia.
CN100439361C (zh) 2003-03-07 2008-12-03 先灵公司 取代的2-吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途
US7459442B2 (en) 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
CA2523035C (en) * 2003-05-22 2011-04-26 Elan Pharma International Ltd. Sterilization of dispersions of nanoparticulate active agents with gamma radiation
US20050096307A1 (en) * 2003-11-05 2005-05-05 Schering Corporation Combinations of lipid modulating agents and substituted azetidinones and treatments for vascular conditions
EP1709112A1 (de) * 2004-01-28 2006-10-11 Unilever Plc Poröse körper und herstellungsverfahren dafür
US7491263B2 (en) 2004-04-05 2009-02-17 Technology Innovation, Llc Storage assembly
EP1870649A1 (de) 2006-06-20 2007-12-26 Octapharma AG Gefriertocknung zum Erzielen einer bestimmte Restfeuchte durch beschränkte Desorptionsenergiepegeln.
US20090238867A1 (en) * 2007-12-13 2009-09-24 Scott Jenkins Nanoparticulate Anidulafungin Compositions and Methods for Making the Same
FR2945950A1 (fr) 2009-05-27 2010-12-03 Elan Pharma Int Ltd Compositions de nanoparticules anticancereuses et procedes pour les preparer
CA3175658A1 (en) 2020-04-16 2021-10-21 Richard Balazs Karpati Methods and compositions for treating prostate cancer
CN114532542A (zh) * 2022-02-24 2022-05-27 山东坦途农业科技有限公司 一种夹心冻干赋型制剂及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2984992A (en) * 1954-07-28 1961-05-23 Union Carbide Corp Apparatus for freeze dehydration of liquid bearing solids
US3309779A (en) * 1966-02-02 1967-03-21 Fmc Corp Dehydration of solids-bearing liquids
GB1190319A (en) * 1968-08-15 1970-05-06 George Jarvis Tooby Method for Dehydrating Materials
DE1900995A1 (de) * 1969-01-09 1970-08-27 Struthers Scient And Internat Gefriertrocknungsverfahren fuer Nahrungsmittel und dabei erhaltene Produkte
FR2036890B1 (de) * 1969-04-15 1973-01-12 Orsymonde
NL6915749A (en) * 1969-10-17 1971-04-20 Powdered products from fruit and vegetable juices aqs - vegetable extracts such as coffee, tea, etc having porous
FR2068447A1 (en) * 1969-11-26 1971-08-27 Orsymonde Dehydrated pharmaceutical comps by - lyophilisation
US3673698A (en) * 1970-11-25 1972-07-04 Albert S Guerard Process for freeze drying with carbon dioxide
JPS503381A (de) * 1973-05-11 1975-01-14
JPS506532A (de) * 1973-05-22 1975-01-23

Also Published As

Publication number Publication date
LU80251A1 (fr) 1979-03-07
US4178695A (en) 1979-12-18
NL7809522A (nl) 1979-03-21
SE7808007L (sv) 1979-03-20
DE2840461C2 (de) 1988-10-06
IT7851099A0 (it) 1978-09-15
GB2004182B (en) 1982-03-24
JPS62884B2 (de) 1987-01-10
SE444645B (sv) 1986-04-28
IE781341L (en) 1979-03-19
NL186675B (nl) 1990-09-03
CA1097209A (en) 1981-03-10
GB2004182A (en) 1979-03-28
FR2403078A1 (fr) 1979-04-13
JPS5495720A (en) 1979-07-28
DE2840461A1 (de) 1979-03-29
FR2403078B1 (de) 1981-07-03
CH633445A5 (fr) 1982-12-15
NL186675C (nl) 1991-02-01
ES473459A1 (es) 1979-10-16
IT1106901B (it) 1985-11-18
DK333678A (da) 1979-03-20
DK154528B (da) 1988-11-21
DK154528C (da) 1989-04-10
IE47020B1 (en) 1983-11-30

Similar Documents

Publication Publication Date Title
BE870548A (fr) Nouveau procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnostic
NL188078C (nl) Farmaceutisch preparaat voor de behandeling van hartarrhytmieen en myocardiale aandoeningen.
MC1336A1 (fr) Procede pour la preparation de compositions pharmaceutiques
NL7810138A (nl) Werkwijze voor de bereiding van roomkaas.
IT1160900B (it) Procedimento per la preparazione di dispersioni dei composti di cerio
NL7803166A (nl) Nieuwe oximverbindingen van 3-acetoxymethyl- -7-amino-thiazolylaceetamidocefalosporaanzuur, werkwijze voor hun bereiding en onder toepassing daarvan verkregen geneesmiddelen.
NL7701849A (nl) Werkwijze voor de bereiding van geneesmiddelen onder toepassing van pyrethrinoiden.
NL187207C (nl) Werkwijze voor de bereiding van pyrrolidineverbindingen.
NL7812643A (nl) N-gesubstitueerde omega-aminoalkanoyl omega-aminoalkaancarbonzuren, toepassing van deze verbindingen, werkwijze ter bereiding van deze verbindingen, benevens geneesmiddelen, die deze verbindingen bevatten.
NL7811251A (nl) Werkwijze voor de bereiding van tereftaalzuur.
NL7606906A (nl) Werkwijze voor de bereiding van thymol.
NL7708009A (nl) Werkwijze voor de bereiding van fosfaatzouten.
NL190119C (nl) Werkwijze voor de bereiding van 4-hydroxy-5-alkyl- en 4-hydroxy-2,5-dialkyl-3-oxo-2h-furanen.
NL187907B (nl) Werkwijze voor de bereiding van fenylglyoxylzuuresters.
NL7803493A (nl) Werkwijze voor de bereiding van thermostabiele weefselvormige melkalbuminen.
NL7807890A (nl) Pyranochromoonderivaten, alsmede preparaten voor de be- handeling van allergische aandoeningen, die deze ver- bindingen bevatten.
NL7800001A (nl) Werkwijze voor de bereiding van nieuwe chromoon- derivaten en de toepassing hiervan als genees- middel tegen hartziekten.
NL7801158A (nl) Werkwijze voor de bereiding van cyclohexaan- derivaten.
BE866662A (fr) Procede de preparation de 3,5-dihalogenanilines
NL7605189A (nl) Werkwijze ter bereiding van geneesmiddelen die 3,5-bisgeoxygeneerde 2-(omega-halogeen-3-geoxy- geneerde-1-alkenyl)-cyclopentaan-1-heptaanzuren en derivaten daarvan bevatten, alsmede de vol- gens deze werkwijze verkregen gevormde preparaten.
NL7812567A (nl) Werkwijze voor de bereiding van menselijke chorionso- matomammotropine.
LU78854A1 (fr) Procede de preparation d'une composition antimicrobienne de nettoyage de la peau
NL7802881A (nl) Werkwijze voor de bereiding van triterpeenver- bindingen.
NL7803559A (nl) Thiobenzylpyrimidine, werkwijze voor de bereiding hier- van en de toepassing van deze stof als geneesmiddel.
PT67885A (fr) Procede de preparation de nouvelles compositions pharmaceutiques destinees notammentau traitement des troubles fonctionnels cerebraux.

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: LABORATOIRE L. LAFON

Effective date: 19980918